Neurocrine Biosciences

Neurocrine Biosciences in Fortune Rankings

Best Large Workplaces in Biotechnology and Pharmaceuticals 2026

Employees say:

"It is stress free. We are treated like adults and we manage our business as if it were our own. We come together as team to share our wins, successes and real life situations. Everyone is seen and heard. This company makes me feel like I make a difference in the lives of so many patients, offices and our own success. It's a great place to work."

  • Updated:10/21/26
  • Country/Territory:U.S.
  • Headquarters:San Diego
  • Industry:Pharmaceuticals
  • CEO:Kyle W. Gano
  • Website:https://www.neurocrine.com
  • Ticker:NBIX
  • Company type:Public
  • Revenues ($M):$3,102
  • Profits ($M):$669
  • Market value ($M):$14,418
  • Number of employees:2,500

Figures are for latest twelve months ended on or before April 30, 2026. Market value as of Sept. 30, 2026.

Neurocrine Biosciences stock chart

Neurocrine Biosciences in Fortune Rankings